Singapore: Australia-based AmpliPhi Biosciences is looking to acquire Brookvale, a Sydney-based Special Phage Services (...
Dr Shinya Yamanaka and Sir John Gurdon's discovery of induced pluripotent stem cells (iPS) has given the world an altern...
Singapore: Researchers at Griffith Health Institute's Genomics Research Center have entered the final phase in an extens...
The Medical Technology Association of Australia (MTAA) is the national association of Australia representing companies i...
Singapore: US-based Ariad Pharmaceuticals has granted Specialised Therapeutics Australia (STA), a specialty pharmaceutic...
Singapore: The federal government in Australia has initiated a review of the patenting of pharmaceuticals in the country...
Singapore: Takeda Development Center Shanghai (TDC Shanghai) and Takeda Development Center Asia has commenced TOURMALINE...
Singapore: Australia based drug development company, CSL, has secured the necessary approvals required to proceed with t...
Singapore: US FDA has accepted the transfer of ownership of 23 generic drug products to Australia based IDT. Formalising...
Singapore: US-based Catalant Pharma Solutions announced the acquisition of Pharmapak Technologies, an Australian pharmac...
Singapore: In a bid to eradicate the menace of TB, The Australian Department of Foreign Affairs and Trade (DFAT) has ann...
Singapore: Australia-based Bionomics has initiated a Phase 1b clinical trial in healthy volunteers of BNC210, the drug c...
Singapore: Specialty pharmaceutical company Hatchtech has completed a $6 million financing led by OneVentures Innovatio...
Singapore: West Australian sandalwood producer TFS Corporation has announced the acquisition of two US pharma firms in a...
Singapore: NICTA start-up company Saluda Medical has been awarded $5 million by the New South Wales Government to suppor...
Singapore: Australian drug development company, Invion, has completed the enrolment in its phase II clinical trial of IN...
Singapore: Clinical research company, CPR Pharma Services, launched a new laboratory, in Adelaide, Australia, to provide...
Singapore: Australian infectious disease therapy and vaccine development company BioDiem has detailed a new phase of res...
